Study of PAT in Patients With Solid Tumor Cancers
NCT05338658
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
21
Enrollment
OTHER
Sponsor class
Conditions
Metastasis
Solid Tumor
Interventions
DRUG:
Peptide Alarm Therapy (PAT)
Sponsor
Masonic Cancer Center, University of Minnesota